| NCT04278235 | Expanded Access to Elezanumab | AbbVie | | - Age ≥ 18 yrs
- Level -
AIS A, B, C, D- All
| Recruiting | | | Drug | General health | | | Never | 20 February 2020 | 0 | |
| NCT02893553 | The Effects of Normalizing Blood Pressure on Cerebral Blood Flow in Hypotensive Individuals With Spinal Cord Injury | James J. Peters Veterans Affairs Medical Center | | - Age 18 - 85 yrs
- Level -
AIS A, B, C, D, E- ≥ 1 years
| Ended | 21 | PHASE2 | Drug | General health | | | 01 December 2016 | 08 September 2016 | 3 | |
| NCT02833428 | Spinal Cord and Artificial Intelligence | Fondation Hôpital Saint-Joseph | | - Age ≥ 18 yrs
- Level -
AIS A, B, C, D- All
| | 1 | NA | Technology | General health | | | 20 January 2018 | 14 July 2016 | 1 | |
| NCT03495986 | Spinal Cord Injury Exercise and Nutrition Conceptual Engagement | University of Miami | | - Age 18 - 65 yrs
- Level C4-T4
AIS A, B- ≥ 12 months
| Ended | 26 | NA | Technology | General health | | | 10 June 2021 | 12 April 2018 | 1 | |
| NCT04142814 | Randomized Controlled Study on T-PEP Versus IPV Method for Lower Respiratory Airways Clearance in Tetraplegic Tracheotomized Spinal Cord Injured Patients | Montecatone Rehabilitation Institute S.p.A. | | - Age ≥ 18 yrs
- Level C4-C7
AIS A- 1 weeks - 5 weeks
| Ended | 0 | NA | Technology | General health | | | 01 February 2022 | 29 October 2019 | 1 | |
| NCT04471714 | Effects of Baclofen on Presynaptic Inhibition in Humans | University of Alberta | | - Age 18 - 65 yrs
- Level -
AIS A, B, C, D- All
| Ended | 0 | PHASE2 | Drug | General health | | | 10 January 2020 | 15 July 2020 | 1 | |
